Cargando…
Multilineage differentiation potential of hematoendothelial progenitors derived from human induced pluripotent stem cells
BACKGROUND: Human induced pluripotent stem cells (hiPSCs) offer a renewable source of cells for the generation of hematopoietic cells for cell-based therapy, disease modeling, and drug screening. However, current serum/feeder-free differentiation protocols rely on the use of various cytokines, which...
Autores principales: | Netsrithong, Ratchapong, Suwanpitak, Siriwal, Boonkaew, Bootsakorn, Trakarnsanga, Kongtana, Chang, Lung-Ji, Tipgomut, Chartsiam, Vatanashevanopakorn, Chinnavuth, Pattanapanyasat, Kovit, Wattanapanitch, Methichit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659123/ https://www.ncbi.nlm.nih.gov/pubmed/33176890 http://dx.doi.org/10.1186/s13287-020-01997-w |
Ejemplares similares
-
Advances in Adoptive Cell Therapy Using Induced Pluripotent Stem Cell-Derived T Cells
por: Netsrithong, Ratchapong, et al.
Publicado: (2021) -
Genetic correction of haemoglobin E in an immortalised haemoglobin E/beta-thalassaemia cell line using the CRISPR/Cas9 system
por: Trakarnsanga, Kongtana, et al.
Publicado: (2022) -
Generation of an immortalised erythroid cell line from haematopoietic stem cells of a haemoglobin E/β-thalassemia patient
por: Trakarnsanga, Kongtana, et al.
Publicado: (2020) -
Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders
por: Wattanapanitch, Methichit
Publicado: (2019) -
ETV2 primes hematoendothelial gene enhancers prior to hematoendothelial fate commitment
por: Steimle, Jeffrey D., et al.
Publicado: (2023)